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Abstract
Lycium barbarum polysaccharides (LBP), extracts from the wolfberries, are protective to retina after ischemia-reperfusion (I/
R). The antioxidant response element (ARE)–mediated antioxidant pathway plays an important role in maintaining the redox
status of the retina. Heme oxygenase-1 (HO-1), combined with potent AREs in its promoter, is a highly effective therapeutic
target for the protection against neurodegenerative diseases, including I/R-induced retinal damage. The aim of our present
study was to investigate whether the protective effect of LBP after I/R damage was mediated via activation of the Nrf2/HO-
1-antioxidant pathway in the retina. Retinal I/R was induced by an increase in intraocular pressure to 130 mm Hg for 60
minutes. Prior to the induction of ischemia, rats were orally treated with either vehicle (PBS) or LBP (1 mg/kg) once a day for
1 week. For specific experiments, zinc protoporphyrin (ZnPP, 20 mg/kg), an HO-1 inhibitor, was intraperitoneally
administered at 24 h prior to ischemia. The protective effects of LBP were evaluated by quantifying ganglion cell and
amacrine cell survival, and by measuring cell apoptosis in the retinal layers. In addition, HO-1 expression was examined
using Western blotting and immunofluorescence analyses. Cytosolic and nuclear Nrf2 was measured using
immunofluorescent staining. LBP treatment significantly increased Nrf2 nuclear accumulation and HO-1 expression in the
retina after I/R injury. Increased apoptosis and a decrease in the number of viable cells were observed in the ganglion cell
layer (GCL) and inner nuclear layer (INL) in the I/R retina, which were reversed by LBP treatment. The HO-1 inhibitor, ZnPP,
diminished the LBP treatment-induced protective effects in the retina after I/R. Taken together, these results suggested that
LBP partially exerted its beneficial neuroprotective effects via the activation of Nrf2 and an increase in HO-1 protein
expression.
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Introduction
Retinal ischemia-reperfusion (I/R) injury is associated with
many ocular diseases, including acute glaucoma and diabetic
retinopathy [1,2]. Interruption of the blood supply to an organ
results in a wide variety of metabolic impairments, and the process
of reperfusion itself is deleterious to injured cells due to the
generation of free radicals and inflammatory cytokines [3].
Oxidative injury is one of the complications after retinal
ischemia-reperfusion injuries accompanied by retinal swelling,
neuronal cell death and glial cell activation [4–6].
Cells have highly developed endogenous antioxidant defense
systems to counteract the oxidative stress generated in many
diseases [7,8]. Antioxidant/electrophile response element (ARE/
EpRE)-regulated phase II detoxifying enzymes and antioxidants is
one of the major antioxidant pathways involved in counteracting
increased oxidative stress and maintaining the redox status in
many tissues [7,9]. Heme oxygenase-1 (HO-1), the rate-limiting
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enzyme that catalyzes the degradation of heme to biliverdin,
carbon oxide (CO) and iron, is one of the ARE-regulated phase II
detoxifying enzymes and antioxidants, which are regulated by the
redox-sensitive transcription factor nuclear factor erythroid 2-
related factor (Nrf2) [10]. Nrf2 demonstrates a protective role
against neuronal and vascular degeneration in retinal ischemia-
reperfusion injury [11]. HO-1 has also been reported to have the
most AREs on its promoter, making it a highly effective
therapeutic target for protection against neurodegenerative
diseases [12]. Overexpression of HO-1 is neuroprotective in a
model of permanent middle cerebral artery occlusion (MCAO) in
transgenic mice [13]. Furthermore, pharmacological induction of
HO-1 has been shown to protect the retina from acute glaucoma-
induced ischemia-reperfusion injury [14].
Lycium barbarum polysaccharides (LBP) is the liquid fraction of
the Lycium barbarum berries (Wolfberry), a traditional Chinese
medicine with proposed anti-aging effects, extracted by a process
involving the removal of the lipid soluble components, such as
zeaxanthin and other carotenoids with alcohol [15]. Numerous
studies have demonstrated the beneficial effects of LBP [16–19].
However, more recent studies have examined its protective effects
in ocular diseases. LBP has been shown to protect retinal ganglion
cells (RGCs) and retinal vasculature in several ocular disease
models, including MCAO-induced retinal ischemia-reperfusion
[20,21]. Furthermore, lycium barbarum extracts protect the brain
from blood-brain barrier disruption and cerebral edema in
experimental stroke [17].
Although there have been many studies on the protective effects
of LBP in various diseases, none of these studies have examined
the contribution of the Nrf2/HO-1 antioxidant pathway. Consid-
ering the beneficial properties of LBP and the potential role of the
Nrf2/HO-1 pathway, we used the acute glaucoma-induced
ischemia-reperfusion model to analyze the mechanisms involved
in the protective effects of LBP in this study. We hypothesized that
the protection of LBP against retinal damage induced by ischemia-
reperfusion injury occurs via activation of the Nrf2/HO-1
pathway.
Materials and Methods
Animals
Eight-week-old male Sprague-Dawley rats (300–350 g) were
housed in a temperature-controlled room. The animals were
maintained on a 12-hour light/12-hour dark schedule. Food and
water were provided ad libitum. Full details of collection and
sampling methods are described in appropriate sections below. At
the end of the experiment, the animals were euthanized by an
overdose of sodium pentobarbital. All of the experiments were
performed in accordance with the Peking University guidelines for
animal research, and the ARVO Statement for the Use of Animals
in Ophthalmic and Vision Research. The experimental animal
protocol used in this study was approved by the Peking University
Institutional Animal Care and Use Committee (IACUC).
Pre-treatment with LBP
Lycium barbarum (wolfberries) was purchased from a local
supermarket from Ning Xia Huizu Autonomous Region, People’s
Republic of China. Its dried fruit was ground into small pieces,
delipidated and deproteinated in alcohol. LBP was then extracted
by using 70uC hot water as described previously [21]. The extracts
were freeze-dried into powder form for storage. For experimental
use, the LBP solution was freshly prepared by dissolving the
powder in phosphate-buffered saline (PBS; 0.01 M; pH 7.4). Rats
were randomly assigned to the following groups: sham-operated
group (eyes were cannulated with a 27-gauge infusion needle
without the elevation of the saline reservoir, Control); vehicle
group (animals were orally fed by gavage with PBS once daily for 1
week followed by 1-hour retinal ischemia, I/R); LBP+I/R group
(animals were orally fed by gavage with LBP (1 mg/kg) once a day
for 1 week followed by 1-hour retinal ischemia); and the LBP+I/
R+ZnPP group (animals were orally fed by gavage with LBP
(1 mg/kg) once a day for 1 week+intraperitoneal injection of ZnPP
(the HO-1 inhibitor, 50 mmol/kg body weight, dissolved in equal
amounts of PBS and 0.1 N NaOH, Sigma-Aldrich Corp., St.
Louis, MO) 24 hours prior to ischemia followed by 1-hour retinal
ischemia). Sulforaphane (SF), a specific Nrf2 inducer, was used as
a positive control to induce the activation of the Nrf2/HO-1
antioxidant pathway in this study. In these experiments, SF
(12.5 mg/kg, Toronto Research Chemicals Inc., North York, ON)
was intraperitoneally administered 24 h prior to ischemia (SF+I/
R). The animals were sacrificed with an overdose of sodium
pentobarbital at 24 h or 7 days after ischemia.
Ischemia-reperfusion Model and Experimental Protocol
The animals were anesthetized with a mixture of ketamine
(80 mg/kg) and xylazine (8 mg/kg). The anterior chamber of the
left eye was cannulated with a 27-gauge infusion needle that was
connected to a physiological saline reservoir. The intraocular
pressure was increased to 130 mm Hg for 60 minutes by elevation
of the saline reservoir. Successful achievement of retinal ischemia
was confirmed by the collapse of the central retinal artery and the
whitening of the iris during the elevation of intraocular pressure
[14].
Detecting ROS Generation
The generation of retinal ROS was assessed using dihydroethi-
dium (DHE; Invitrogen Molecular Probes, Eugene, OR) as
previously described. Briefly, fresh retinas were harvested and
quickly frozen in liquid nitrogen for cryosectioning (Leica
CM1950; Leica Microsystems Ltd, Wetzlar, Germany). Cryosec-
tions (10 mm) were washed with a warm PBS solution and then
incubated with 5 mM dihydroergotamine (DHE) in PBS for 30
minutes at 37uC. DHE specifically reacts with superoxide anions
and is converted to the red fluorescent compound ethidium. The
sections were examined and imaged using an inverted fluorescent
microscope equipped with a digital camera (Eclipex Ti-S; Nikon
Instech Co., Tokyo, Japan) under identical exposure conditions,
and the optical densities of the staining in the outer nuclear layer
(ONL), inner nuclear layer (INL), and ganglion cell layer (GCL)
were measured from randomly selected images. Five measure-
ments were obtained at 200 mm intervals using a commercial
software program (Photoshop CS5; Adobe Corp., San Jose, CA).
Immunohistochemistry
RNA binging protein with multiple splicing (RBPMS)
antibody generation. A rabbit polyclonal antibody was gen-
erated against the N-terminus of the RNA Binding Protein
Multiple Splice (RBPMS) polypeptide (RBPMS4-24), GGKAE-
KENTPSEANLQEEEVR by a commercial vendor (ProSci,
Poway, CA). RBPMS is highly conserved among mammals and
the polypeptide sequence used for immunization is identical in
mouse, rat, monkey and human (NCBI Protein Bank, http://
www.ncbi.nlm.nih.gov/protein). Rabbit sera were collected fol-
lowing immunization and affinity purified using a RBPMS
polypeptide affinity column. The affinity purified antibody was
shown to immunostain ganglion cells in mouse and rat retina
(Rodriguez et al., 2013, submitted). To evaluate the specificity of
the RBPMS immunostaining, a preabsorption control was
The Nrf2/HO-1 Pathway and Antioxidant Protection
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performed with the rabbit antibody. Briefly, the RBPMS antibody
was diluted in 0.1 M PB containing 0.5% Triton X-100 and mixed
with the RBPMS polypeptide at a final concentration of 1 mg/ml
for two hours at RT. No RBPMS immunostaining was present in
tissue sections incubated with the rabbit antibody preabsorbed to
RBPMS and processed by standard immunohistochemical tech-
niques.
We used immunofluorescence to examine the localization and
number of choline acetyltransferase (ChAT)-positive amacrine
cells and RBPMS–positive ganglion cells in the retina. Localiza-
tion and expression of HO-1 and Nrf2 were also examined using
immunofluorecent staining. Apoptotic cells were stained using a
TdT-mediated dUTPnick-end labeling (TUNEL)–based kit (Life
Technologies, Grand Island, NY). Briefly, the eyes were enucle-
ated, postfixed in 4% paraformaldehyde for 45 minutes, and
embedded in OCT. Sections were transversely cut along the
temporal-nasal axis of the eyeball. To ensure comparability, only
sections that contained the optic nerve stump were used in this
comparative study. Three retinal sections per animal were
sampled to increase the reliability of the data, and the numbers
obtained were pooled to obtain the final number of immuno-
stained cells in each retina. The cryosections (10 mm) were thawed,
air-dried, and washed three times with 0.01 M PBS (pH 7.4).
Tissue specimens were first treated with 3% BSA (Sigma-Aldrich
Corp., St. Louis, MO) in 0.3% Triton X-100 for 20 minutes at
room temperature and then incubated with one of the following
primary antibodies: goat polyclonal antibody against ChAT
(Millipore Corp, Billerica, MA), rabbit polyclonal antibody against
RBPMS, rabbit polyclonal antibody against HO-1 (Stressgen, Inc.,
San Diego, CA) or rabbit polyclonal antibody against Nrf2 (Santa
Cruz Biotech Inc. Dallas, TX). Immunoreactivity was detected
using a FITC-labeled secondary antibody (Abcam Inc., Cam-
bridge, MA), and the cell nuclei were counterstained with 49-6-
diamidino-2-phenylindole (DAPI). The number of ChAT-,
RBPMS- and TUNEL-positive cells in both the GCL and INL,
and cells with Nrf2 nuclear accumulation in the GCL was
quantified, respectively, in each section under a fluorescent
microscope. For quantification of Nrf2, images of Nrf2 staining
Figure 1. LBP inhibits ischemia-reperfusion-induced retinal cell apoptosis. Apoptotic cells in the I/R retina were stained using a TUNEL-kit
as previously described in the Methods section. A, B: Representative micrographs of TUNEL-stained retinal sections obtained at 24 h (A) or 7 days (B)
after ischemia. C, Quantitative analysis of TUNEL-positive cells in the retina (mean 6 SEM, n = 5). Control: sham-operated animal, I/R: vehicle-treated
animal with 1 h ischemia, and LBP+I/R: LBP-pretreated animal with 1 h ischemia. ***p,0.001 compared to I/R at the same time point. Scale bar:
20 mm. GCL: ganglion cell layer; INL: inner nuclear layer; ONL: outer nuclear layer.
doi:10.1371/journal.pone.0084800.g001
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(green) and DAPI staining (blue) of the same area were merged
together to locate the cells with nuclear Nrf2 accumulation. The
color of DAPI staining was converted to red using a commercial
software program (Photoshop CS5; Adobe Corp., San Jose, CA)
before merging.
Western Blotting Analyses
The eyes were enucleated, and the retinas were collected and
flash-frozen at 280uC within 2 minutes of enucleation. The
retinas were subsequently ultrasonically homogenized at 4uC in
300 mL RIPA buffer containing 50 mM Tris (pH 7.4), 150 mM
NaCl, 10 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% sodium
deoxycholate, 1 mM Na3VO4, 1 mM NaF, 1 mM EGTA, 1 mM
phenylmethylsulfonyl fluoride, and proteinase inhibitors. The
protein concentrations were determined using a BCA protein
assay to ensure equal protein loading, and 20 mg of protein in each
lane were separated by 10% or 12% SDS-PAGE. Next, the
proteins were transferred onto a nitrocellulose membrane (Milli-
pore Corp, Billerica, MA) and then blocked and probed with
either rabbit polyclonal anti–HO-1 (Stressgen Biotech Inc,
Philadelphia, PA.) antibody or goat polyclonal antibody against
ChAT (Millipore Corp, Billerica, MA). A peroxidase-conjugated
anti–rabbit secondary antibody (PerkinElmer, Inc., Wellesley,
MA) was used, and the blots were also probed for b-actin (Sigma-
Aldrich Corp.) as a loading control. The protein bands were
visualized using the ECL Western blotting detection reagent (GE
Healthcare Life Science, Uppsala, Sweden) according to the
manufacturer’s instructions. For quantification, blots from at least
five independent experiments (5 animals per group) were
quantified using Image J software.
Figure 2. LBP protects retinal ganglion cells from ischemia-reperfusion-induced damage. Retinal ganglion cells were stained with a
specific retinal ganglion cell marker, Rbpms. A, B: Representative micrographs of Rbpms-stained retinal sections obtained at 24 h (A) or 7 days (B)
after ischemia. C, Quantitative analysis of Rbpms-positive cells in the retinal ganglion cell layer (mean6 SEM, n= 5). Control: sham-operated animal, I/
R: vehicle-treated animal with 1 h ischemia, and LBP+I/R: LBP-pretreated animal with 1 h ischemia. *p,0.05, ***p,0.001 compared to control,
## p,0.01, ### p,0.001 compared to I/R at the same time point. Scale bar: 20 mm. GCL: ganglion cell layer; INL: inner nuclear layer; ONL: outer
nuclear layer.
doi:10.1371/journal.pone.0084800.g002
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Statistical Analysis
The data were expressed as the means 6 SEM. Analysis
between multiple groups was performed using one-way ANOVA
analysis followed by Bonferroni multiple comparison post-tests.
P,0.05 was considered statistically significant.
Results
LBP Protected Retinal Cells against Apoptosis after I/R
As shown in Figure 1, ischemia for 1 h and reperfusion for 24 h
(Fig. 1 A) or 7 days (Fig. 1 B) resulted in significant increases in the
number of TUNEL-positive cells in the retina, predominantly in
the INL and GCL, indicating that ischemia/reperfusion results in
cell apoptosis in the retina. Significantly less TUNEL-positive cells
were found in the INL and GCL in LBP-pretreated retinas when
compared to vehicle-treated retinas at both 24 h and 7 days after
I/R, suggesting that pretreatment with LBP (1 mg/kg body
weight) for 1 wk significantly protected retinal cells against I/R-
induced damage. Moreover, these protective effects persisted for at
least 7 days.
LBP Protected Retinal Ganglion Cells from I/R Damage
To further demonstrate whether pretreatment of LBP exhibited
protective effects on retinal ganglion cells after I/R-induced
damage, a specific marker of RGCs, RBPMS [22,23], was used in
this study. As shown in Figure 2, ischemia for 1 h and reperfusion
for 24 h resulted in a nearly 50% decrease in the number of
RGCs. At 7 days after ischemia, only 30% of RGCs remained in
the retina. However, in the LBP-pretreated animals, the rate of
RGC loss was delayed. In addition, more than 50% of the RGCs
were in the retina 7 days after the ischemic insult.
Figure 3. LBP protects retinal amacrine cells against ischemia-reperfusion-induced damage. Retinal amacrine cells were stained with
anti-ChAT antibody. A, B: Representative micrographs of retinal sections stained with anti-ChAT antibody at 24 h (A) or 7 days (B) after ischemia. C:
Quantitative analysis of ChAT-positive cells in the GCL and INL (mean 6 SEM, n = 5). D, E: Representative immunoblot of ChAT levels in whole retina
(upper panel) at 24 h (D) or 7 days (E) after ischemia and densitometric analysis of ChAT expression relative to loading control (lower panel) (mean6
SEM, n= 5). Control: sham-operated animal, I/R: vehicle-treated animal with 1 h ischemia, and LBP+I/R: LBP-pretreated animal with 1 h ischemia.
*p,0.05, ***p,0.001 compared to control, # p,0.05, ### p,0.001 compared to I/R at the same time point. Scale bar: 20 mm. GCL: ganglion cell
layer; INL: inner nuclear layer; ONL: outer nuclear layer.
doi:10.1371/journal.pone.0084800.g003
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LBP Protected Retinal Amacrine Cells from I/R Damage
A choline acetyltransferase (ChAT) antibody was used as a
marker for cholinergic neurons in the retina. As shown in
Figure 3A, in the non-ischemic control retina, ChAT-positive
amacrine cells were present in the GCL and innermost layer of the
INL. At 24 h after I/R, the number of ChAT-positive cells in the
two cellular layers in the vehicle-treated I/R retina was much less
compared to the non-ischemic control retina. Conversely, when
compared with the vehicle-treated I/R retina, the LBP-treated I/
R retina had an increase in the number of ChAT-positive cells.
Similar results were observed in the retina 7 days after I/R
(Figure 3B). These results were further confirmed by an
immunoblotting study. As shown in Figures 3D and 3E, the
ChAT protein levels in vehicle-treated I/R retinas were signifi-
cantly less compared to the non-I/R retina, and LBP-pretreatment
significantly upregulated ChAT levels in the retina after I/R.
LBP Downregulated ROS Generation in I/R Retinas
The generation of ROS in fresh retinas was detected using
DHE staining. As shown in Fig. 4, the basal level of ROS in non-
ischemic control retinas was low (Fig. 4A–a). However, after 1 h of
ischemia followed by 24 hrs of reperfusion, there was a dramatic
increase in ROS generation in the entire retina (Fig. 4A–b). This
effect was significantly decreased with LBP pretreatment (Fig. 4 A–
c).
LBP Upregulated the Nuclear Translocation of Nrf2 in
RGCs
In non-ischemic retinas, Nrf2 was diffusely displaced in the
cytosol and nuclei of cells (Fig. 5 A). In vehicle-treated retinas at
24 h after I/R insult, retinal cells, especially cells in the GCL,
displayed increased nuclear accumulation of Nrf2 as indicated by
an increase in immunointensity of nuclear Nrf2 (Fig. 5 B).
Moreover, LBP pretreatment further increased Nrf2 nuclear
accumulation in the GCL (Fig. 5 C). At 7 days after I/R insult, I/
R-induced Nrf2 nuclear accumulation was nearly diminished
because very few cells were found with Nrf2 nuclear accumulation
in the vehicle-treated I/R retina (Fig. 5 E). However, in the LBP-
pretreated retina, cells with Nrf2 nuclear accumulation could still
be found in the GCL (Fig. 5 F). Quantification analyses indicated
that LBP pretreatment significantly increased the number of cells
with accumulated nuclear Nrf2 in the GCL in retinas at 24 h and
7 days after I/R insult (Fig. 5 P). Furthermore, a specific Nrf2
activator, sulforaphane, was used to compare the effectiveness of
LBP on Nrf2 activation. The effect of LBP on Nrf2 activation was
similar to that of sulforaphane (data not shown).
LBP Upregulated the Expression of HO-1 in the Retina
Nrf2 is one of the transcription factors that regulate the
expression of HO-1. Because LBP pretreatment induced an
increase in the number of cells with nuclear accumulated Nrf2, the
expression of HO-1, a downstream target gene of Nrf2, was
examined using immunofluorescent staining and Western blotting
analysis. As shown in Figure 6, non-ischemic control retinas have a
relatively low HO-1 immunoreactivity (Fig. 6 A–a). In addition,
24 h after an ischemia insult, I/R induced robust immunoreac-
tivity of HO-1 in the retina (Fig. 6 A–b). Pretreatment of LBP
further enhanced HO-1 immunoreactivity in the retina after I/R
(Fig. 6 A–c). These results were further confirmed by immuno-
blotting. As shown in Figure 6 C, the basal levels of HO-1 in the
non-ischemic retina was low. However, I/R could induce an
increase in the expression of HO-1 in the retina, although this
increase failed to reach statistical significance. Moreover, LBP
Figure 4. LBP reduces ROS generation in the retina after ischemia-reperfusion. ROS generation in fresh retinas was detected using DHE
staining. (A) Representative micrographs of retinal sections stained with DHE (24 h after ischemia). (B) Quantitative analysis of ROS levels in the whole
retina. The fluorescent intensities of the DHE-labeled neurons were quantified using an image analysis software program (Adobe Photoshop CS5;
Adobe Corp.) (mean 6 SEM, n = 5). ***p,0.001 compared to control, ### p,0.001 compared to I/R. Scale bar: 20 mm. Control: sham-operated
animal, I/R: vehicle-treated animal with 1 h ischemia, and LBP+I/R: LBP-pretreated animal with 1 h ischemia. GCL: ganglion cell layer; INL: inner
nuclear layer; ONL: outer nuclear layer.
doi:10.1371/journal.pone.0084800.g004
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pretreatment significantly enhanced I/R-induced HO-1 expres-
sion. At 7 days after I/R insult, HO-1 immunoreactivity in the
vehicle-treated I/R retina was nearly diminished or had returned
to basal levels, whereas in the LBP-pretreated I/R retina, HO-1
immunoreactivity was still strong in the whole retina (Figure 6 B).
Immunoblotting study has also revealed similar findings (Fig. 6 D).
Similar to the Nrf2 studies, sulforaphane was also used as a
positive control in the HO-1 experiments. The effect of LBP on
the activation of HO-1 was similar to that of sulforaphane (Fig. 6
C).
Inhibition of HO-1 Activity Abolished the LBP-induced
Protective Effects in the Retina after I/R
To further investigate whether the protective effects of LBP
on ganglion and amacrine cells in the I/R retina were mediated
via activation of the Nrf2/HO-1 antioxidant pathway, a specific
inhibitor of HO-1, ZnPP[14], was used. As shown in Figure 7,
when pretreated with ZnPP, the number of RBPMS- and
ChAT-positive cells in the LBP-pretreated I/R retina was
decreased to levels similar to that observed in the vehicle-treated
I/R retina.
Discussion
The present study investigated the effects of LBP on retinal cells
and the activation of the Nrf2/HO-1 antioxidant pathway in I/R
retinas. Our data demonstrated that I/R induction enhanced
ROS generation and increased the apoptosis of ganglion and
amacrine cells in the retina. The Nrf2/HO-1 antioxidant pathway
was adaptively activated to counteract the I/R-induced damage in
the retina. LBP pretreatment did not only reduce the generation of
ROS, but it also enhanced the activation of the Nrf2/HO-1
antioxidant pathway in I/R retinas. Furthermore, inhibition of
HO-1 activity significantly blocked LBP-induced protective effects
on I/R retinas, suggesting that the protective effects of LBP in I/R
retinas was mediated, at least partly, by the activation of the Nrf2/
HO-1 antioxidant pathway. Despite numerous studies on the
Figure 5. LBP enhanced nuclear Nrf2 accumulation in the retina after ischemia-reperfusion. The localization and expression of Nrf2 was
determined by immunofluorescent staining using a specific anti-Nrf2 antibody (green). DAPI was used to counterstain the nucleus (blue). A–E:
Representative micrographs of retinal sections stained with anti-Nrf2 at 24 h or 7 days after ischemia with or without LBP-pretreatment. F–J: Nucleus
of cells shown in panel A-E were counterstained with DAPI; K–O: Merged images of A-E and F-J with the color of DAPI converted to red by Photoshop
as described in the Methods; P: Quantitative analysis of nuclear Nrf2-positive cells in the retinal ganglion cell layer (mean 6 SEM, n = 5). Control:
sham-operated animal, I/R: vehicle-treated animal with 1 h ischemia, and LBP+I/R: LBP-pretreated animal with 1 h ischemia. ***p,0.001 compared to
control,### p,0.001 compared to I/R at the same time point. Scale bar: 20 mm. GCL: ganglion cell layer; INL: inner nuclear layer; ONL: outer nuclear
layer.
doi:10.1371/journal.pone.0084800.g005
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protective effects of LBP in various diseases, to the best of our
knowledge, our study is the first to demonstrate the contribution of
the Nrf2/HO-1 antioxidant pathway to the protective effects of
LBP in the I/R retina.
High intraocular pressure–induced retinal ischemia is a
frequently used model for retinal ischemic studies [14,21,24].
This method produces global ischemia via the obstruction of both
retinal and choroidal circulation, contributing to pathological
features that are nearly identical to those observed in patients after
a central retinal artery occlusion or ophthalmic artery occlusion.
However, this model may also represent acute angle-closure
glaucoma. Neuronal cell death, glial cell activation, retinal
swelling, and oxidative injury are complications found in retinal
ischemia-reperfusion injuries [14,20].
Lycium barbarum is a dried fruit that is used as a food or
medicine according to Chinese tradition [25]. Chemical compo-
sition analyses demonstrated that LBP consisted of several
monosaccharides, namely glucose, fructose and xylose [26,27]. It
has been proposed that LBP provides anti-aging [28], anti-tumor
[29,30], cytoprotective [15], and neural modulatory [31] effects.
Figure 6. LBP upregulates the expression of HO-1 in the retina after ischemia-reperfusion. HO-1 expression in the retina was determined
using immunofluorescent staining and immunoblotting. A, B: Representative micrographs of retinal sections stained with anti-HO-1 antibody at 24 h
(A) or 7 days after ischemia. C, D: Representative immunoblot of HO-1 protein levels in whole retina at 24 h (C) and 7 days (D) after ischemia (upper
panel) and densitometric analysis of HO-1 expression relative to the loading control (lower panel, mean 6 SEM, n= 5). Control: sham-operated
animal, I/R: vehicle-treated animal with 1 h ischemia, LBP+I/R: LBP-pretreated animal with 1 h ischemia, SF+I/R: sulforaphane-pretreated animal with
1 h ischemia. **p,0.01, ***p,0.001 compared to control, # p,0.05 compared to I/R. Scale bar: 20 mm. GCL: ganglion cell layer; INL: inner nuclear
layer; ONL: outer nuclear layer.
doi:10.1371/journal.pone.0084800.g006
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Furthermore, LBP can reduce exercise-induced oxidative damage
by decreasing plasma MDA formation and increasing SOD and
GPx activity [19,32]. It has also been shown that LBP can also
protect multiple tissues against oxidative damage in streptozotocin-
induced diabetic rats [32,33] and in aged mice [28]. In mice, LBP
protected the liver from carbon tetrachloride-induced oxidative
stress and necroinflammation [34]. As an antioxidant, the
cardioprotective effect of LBP has been demonstrated in acute
doxorubicin-induced cardiotoxicity in beagle dogs [35] and in rats
with cardiac ischemia-reperfusion injury [26]. Moreover, LBP also
enhanced the levels of in vivo antioxidant biomarkers in the serum
of healthy adults [16]. The protective effects of LBP against ocular
diseases have also been recently demonstrated. Pre-treatment with
LBP for 1 week effectively protected the retina against neuronal
death, apoptosis, glial cell activation, aquaporin water channel
upregulation, disruption of the blood-retina barrier and oxidative
stress in MCAO and acute ocular hypertension-induced I/R
retinas [20,21]. Consistent with these results, the present study
revealed that LBP pretreatment directly attenuated ROS gener-
ation and reduced retinal ganglion cell and amacrine cell apoptosis
after I/R.
Heme oxygenase-1 (HO-1) is a rate-limiting enzyme, which
catalyzes the degradation of heme into carbon monoxide,
biliverdin, and ferritin [36]. The regulation of HO-1 gene
expression occurs on multiple levels and is inducer-specific [37–
39]. At the transcriptional level, HO-1 is mediated by the
transcription factor Nrf2 [9,11]. Under physiological conditions,
Nrf2 is sequestered in the cytosol by Keap1 and is targeted for
proteasomal degradation [40,41]. In the presence of electrophiles
or ROS, Nrf2 is released from Keap1 and then translocates into
the nucleus, activating the transcription of target genes, including
HO-1. As shown in this study, I/R injury resulted in a dramatic
increase in ROS generation in the retina. Consequently, nuclear
Nrf2 was increasingly accumulated and endogenous HO-1 was
upregulated in the retinas after ischemia-reperfusion injury.
However, this adaptive activation was temporary and had
diminished at 7 days after ischemia-reperfusion injury. Pretreat-
ment of LBP significantly enhanced and prolonged the activation
of the Nrf2/HO-1 antioxidant pathway for up to 7 days after I/R
injury and consequently protected retinal ganglion cells and
amacrine cells against I/R-induced damage. In addition to LBP,
many other neuronal protective agents, such as flavonoid [42,43],
Figure 7. Abolishment of the protective effects of LBP after ischemia-reperfusion by the HO-1 inhibitor in retina. The involvement of
HO-1 in the protective effects of LBP after ischemia-reperfusion in the retina was determined using the specific HO-1 inhibitor, ZnPP. A:
Representative micrographs of retina sections stained with the RGC specific marker, Rbpms at 24 h after ischemia B: Quantitative analysis of Rbpms-
positive cells in the retinal ganglion cell layer (mean6 SEM, n = 5). C: Representative micrographs of retina sections stained with the amacrine specific
marker anti-ChAT at 24 h after ischemia. D: Quantitative analysis of ChAT-positive cells in the GCL and INL (mean 6 SEM, n = 5). I/R: vehicle-treated
animal with 1 h ischemia, LBP+I/R: LBP-pretreated animal with 1 h ischemia, LBP+I/R+ZnPP: LBP-pretreated animal with ZnPP injection 24 h before
1 h ischemia. **p,0.01, ***p,0.001 compared to I/R, ## p,0.01, ### p,0.001 compared to LBP+I/R. Scale bar: 20 mm. GCL: ganglion cell layer;
INL: inner nuclear layer; ONL: outer nuclear layer.
doi:10.1371/journal.pone.0084800.g007
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reservatol (which is rich in polyphenol [44]), and sulforaphane
have shown beneficial effects in the treatment of I/R-related
neuronal diseases [45,46] via the activation of the Nrf2/HO-1
antioxidant pathway. Studies using transgenic mice have also
shown that pharmacological stimulation of HO-1 activity may
ameliorate ischemic injury during the acute period of stroke [13],
and pharmaceutical induction of HO-1 by the HO-1 activator
CoPP ameliorated retinal damage due to I/R injury [14,47,48].
The most recent study by Varga et al demonstrated that activation
of HO-1 was also involved in alpha-melanocyte-stimulating
hormone (a-MSH)-induced protection of I/R retina [49,50].
The cytoprotective properties of HO-1 are due to the by-products
of HO-1-catalyzed heme cleavage, i.e., iron, bilirubin, and CO.
Biliverdin and bilirubin are potent antioxidants, which scavenge
peroxy radicals and inhibit lipid peroxidation [51]. CO shares
some properties with NO, such as its effects on intracellular
signaling processes, including anti-inflammatory, anti-proliferative,
anti-apoptotic, and anti-coagulative effects [52]. The anti-inflam-
matory and anti-apoptotic effects of CO can reduce macrophage
recruitment as well as ganglion and amacrine cell apoptosis as
demonstrated in the present study after LBP pretreatment.
Previous studies have also shown that pharmaceutical induction
of HO-1 reduced macrophage recruitment and retinal cell
apoptosis. Furthermore, enhancement of HO-1 expression after
ischemia may extend neuronal survival [14]. In the present study,
we demonstrated that pretreatment of LBP for 1 wk significantly
enhanced Nrf2 nuclear accumulation and HO-1 expression after
I/R injury. Concurrently, macrophage recruitment, and ganglion
cell and amacrine cell apoptosis were also significantly inhibited by
LBP pretreatment. Taken together, these results suggested that
activation of the Nrf2/HO-1 antioxidant pathway contributed to
the protective effects of LBP in the retina after I/R injury.
Moreover, the involvement of HO-1 in the beneficial effects of
LBP in the retina was further demonstrated using the HO-1
inhibitor ZnPP. As shown in the present study, ZnPP treatment
significantly blocked the LBP-induced protective effects in the
retina, including the prevention of macrophage recruitment and
inhibition of ganglion cell and amacrine cell apoptosis after I/R
injury. Taken together, our study demonstrated that the Nrf2/
HO-1 antioxidant pathway contributes to the protective effects of
LBP in the rodent retina after I/R-induced damage. Pretreatment
with LBP may also strongly potentiate the cell’s adaptive
antioxidant ability.
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